Look for:

GLAXOSMITHKLINE ORD GBP0.25


ISIN:
GB0009252882
WKN:
0925288

2021/02/25 17:38:08
Price
1,216.00 GBp
Difference 0.25% (3.00)

General attributes

ISINGB0009252882
SymbolGSK
ExchangeLondon Stock Exchange
CurrencyGBp
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)70,732 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,215.00 GBp (1,335)
Ask (Ask size)1,215.60 GBp (485)
Open1,215.00 GBp
High1,220.40 GBp
Low1,204.80 GBp
Close (prev. day)1,213.00 GBp
VWAP1,213.690218 GBp
Volume (pcs)6,012,069
Trading volume7,296,789,338.00
Number of trades12,641
Last size-

Futures and Options

Related Futures43
Related Options-

PDF Downloads

Annual report: GLAXOSMITHKLINE ORD GBP0.25PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/02/25 17:38:08
Price
1,216.00 GBp
Difference 0.25% (3.00)

General attributes

ISINGB0009252882
SymbolGSK
ExchangeLondon Stock Exchange
CurrencyGBp
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)70,732 EUR
BenchmarkFTSE 100

Market data

Bid (Bid size)1,215.00 GBp (1,335)
Ask (Ask size)1,215.60 GBp (485)
Open1,215.00 GBp
High1,220.40 GBp
Low1,204.80 GBp
Close (prev. day)1,213.00 GBp
VWAP1,213.690218 GBp
Volume (pcs)6,012,069
Trading volume7,296,789,338.00
Number of trades12,641
Last size-

Performance and Risk

6M1Y3Y
Perf (%)-16.52%-26.64%-4.23%
Perf (abs.)-2.84-5.21-0.63
Beta0.870.660.70
Volatility21.5132.2723.55
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1,217.48 GBp (10,854,860)
Ø price 30 days | Ø volume 30 days (pcs.)1,317.97 GBp (8,754,479)
Ø price 100 days | Ø volume 100 days (pcs.)1,365.71 GBp (8,094,891)
Ø price 250 days | Ø volume 250 days (pcs.)1,492.26 GBp (8,032,071)
YTD High | date1,446.60 GBp (2021/01/07)
YTD Low | date1,196.00 GBp (2021/02/23)
52 Weeks High | date1,772.51 GBp (2020/04/02)
52 Weeks Low | date1,196.00 GBp (2021/02/23)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/02/2517:3514.27 EUR2.33209
Tradegate2021/02/2517:5414.182 EUR0.81194
Stuttgart2021/02/2516:4614.238 EUR0.0416
SIX Swiss Exchange2020/04/2117:3621.50 CHF0.001
Munich2021/02/2515:5814.19 EUR0.023
London Stock Exchange2021/02/2517:381,215.60 GBp7,296.7912,641
Hanover2021/02/2508:0214.328 EUR0.001
Hamburg2021/02/2516:2914.248 EUR0.032
Frankfurt2021/02/2517:3714.20 EUR0.0917
FINRA other OTC Issues2021/02/2516:5416.95 USD0.128
Duesseldorf2021/02/2508:2014.322 EUR0.001
Berlin2021/02/2508:0814.322 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2549&ID_TYPE_IMAGE_LOGO=2

Contact Details

GLAXOSMITHKLINE PLC
- -
Great West Road 980 TW8 9GS UK-Brentford, Middlesex
Telefon: +44-20-8047-5000
Fax: -
E-mail: GSK.Investor-Relations@gsk.com

PDF Downloads

Annual report: GLAXOSMITHKLINE ORD GBP0.25PDF Download

Company Profile

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.

Members of Management Board

Emma WalmsleyChairman of Managing Board
Sally JacksonMember of Executive Committee
Roger ConnorMember of Executive Committee
Regis SimardMember of Executive Committee
Phil ThomsonMember of Executive Committee
Nick HironsMember of Executive Committee
Luke MielsMember of Executive Committee
Karenann TerrellMember of Executive Committee
James FordMember of Executive Committee
Iain MackayMember of Executive Committee
Diana ConradMember of Executive Committee
Deborah WaterhouseMember of Executive Committee
David RedfernMember of Executive Committee
Brian McNamaraMember of Executive Committee
Hal BarronMember of Executive Committee

Board of directors

Jonathan SymondsChairman of Supervisory Board
Urs RohnerMember of Supervisory Board
Manvinder Singh BangaMember of Supervisory Board
Lynn ElsenhansMember of Supervisory Board
Judy LewentMember of Supervisory Board
Iain MackayMember of Supervisory Board
Emma WalmsleyMember of Supervisory Board
Charles BancroftMember of Supervisory Board
Vivienne CoxMember of Supervisory Board
Laurie GlimcherMember of Supervisory Board
Jesse GoodmanMember of Supervisory Board
Hal BarronMember of Supervisory Board





Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.